Vicarious Surgical RBOT
OTC RBOT
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025)

Vicarious Surgical's (RBOT) quarterly Cash from Investing Activities came in at $9.7 million in Q3 2025, up 2069.92% year-over-year from $446652.7 in Q3 2024, and down 34.6% quarter-over-quarter from $14.8 million in Q2 2025.

Analysis

Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has reported Cash from Investing Activities for 6 consecutive years, with $9.7 million the latest figure, recorded in Q3 2025.

  • On a quarterly basis, Cash from Investing Activities rose 2069.92% year-over-year to $9.7 million in Q3 2025; TTM through Sep 2025 was $43.6 million, a 1814.16% increase from a year earlier, with the FY2024 full-year figure at $6.9 million, up 114.99% from the prior year.
  • Cash from Investing Activities was $9.7 million for Q3 2025 at Vicarious Surgical, down from $14.8 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $14.8 million in Q2 2025 and troughed at -$43.8 million in Q1 2023.
  • A 5-year average of -$865105.3 and a median of -$492000.0 in 2024 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities plunged 2067.56% in 2023 and surged 3303.47% in 2025, its largest moves.
  • Over 5 years, Cash from Investing Activities stood at -$867000.0 in 2021, then declined by 14.42% to -$992000.0 in 2022, then jumped by 608.57% to $5.0 million in 2023, then jumped by 186.42% to $14.4 million in 2024, then plunged by 32.93% to $9.7 million in 2025.
  • The last three Cash from Investing Activities figures came in at $9.7 million (Q3 2025), $14.8 million (Q2 2025), and $4.6 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -1.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -193.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 329.80 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -108.50 Mn
10 Vicarious Surgical 231,626.35 -14.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 9.69 Mn
Jun 30, 2025 14.82 Mn
Mar 31, 2025 4.61 Mn
Dec 31, 2024 14.45 Mn
Sep 30, 2024 -492,000.00
Jun 30, 2024 -6.95 Mn
Mar 31, 2024 -144,000.00
Dec 31, 2023 5.05 Mn
Sep 30, 2023 -644,000.00
Jun 30, 2023 -6.36 Mn
Mar 31, 2023 -43.83 Mn
Dec 31, 2022 -992,000.00
Sep 30, 2022 -782,000.00
Jun 30, 2022 -1.56 Mn
Mar 31, 2022 -2.02 Mn
Dec 31, 2021 -867,000.00
Sep 30, 2021 -82,000.00
Jun 30, 2021 -212,000.00
Mar 31, 2021 -128,000.00
Dec 31, 2020 -345.00 Mn